Forian Inc., a provider of data science driven information and analytics solutions, reported financial results for the fourth quarter and full year ended December 31, 2025, highlighting substantial revenue growth alongside strategic investments that impacted short-term profitability. The company's full-year revenue increased by 50% to $30.3 million from $20.2 million in the prior year, while fourth-quarter revenue grew 37% to $8.0 million. This performance demonstrates the company's expanding market presence in life sciences, healthcare, and financial services sectors.
Despite the revenue growth, Forian reported a net loss of $2.9 million for the full year, an improvement from the $3.8 million loss in 2024. The fourth quarter showed a net loss of $1.8 million compared to net income of $0.2 million in the same period last year. Adjusted EBITDA, a non-GAAP measure the company uses to evaluate performance, showed improvement for the full year at $0.8 million compared to $0.5 million in 2024, though it turned negative in the fourth quarter at $(0.2) million. Chief Executive Officer Max Wygod stated that the company demonstrated "disciplined cost management and strategic investment can go hand in hand" during 2025.
The company's financial position remained strong with cash, cash equivalents and marketable securities totaling $31.6 million at year-end. Forian highlighted several operational achievements including meeting its revenue guidance target through key contract renewals, achieving targeted Adjusted EBITDA margins, and strengthening its data platform through expanded contracting activity and new clinical data feeds. The company also noted growing pharmaceutical and biotech adoption of its offerings.
A significant corporate development emerged on August 25, 2025, when a consortium led by Forian's Chief Executive Officer and Executive Chair submitted a non-binding proposal to acquire all outstanding shares not currently owned by the consortium. A Special Committee formed to evaluate this proposal remains in place and is in discussions with the consortium. The company cautioned that there can be no assurance that any transaction will result from these discussions. For more detailed financial information, investors can visit the company's website at https://www.forian.com.
The company's results reflect the challenges of balancing growth investments with profitability in the competitive data analytics sector. Forian's expansion into new markets and strengthening of its data foundation position the company for future opportunities, though the potential acquisition talks add uncertainty to its corporate trajectory. The mixed financial metrics—strong revenue growth alongside net losses—illustrate the company's transitional phase as it invests in platform development while managing operational costs.
